Avanos Medical (AVNS) Cash from Discontinued Operations (2018)

Avanos Medical's (AVNS) quarterly Cash from Discontinued Operations came in at 89900000.0 in Q2 2018.

Avanos Medical (AVNS) Cash from Discontinued Operations (2018) Analysis & Trends

Avanos Medical has disclosed Cash from Discontinued Operations across 1 years of filings, most recently posting 89900000.0 for Q2 2018.

Cash from Discontinued Operations for Q2 2018 came in at 89900000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2019 was 89900000.0 (changed 0.0% YoY), and the FY2018 annual result was 98400000.0, changed N/A from the prior year.
Cash from Discontinued Operations came in at 89900000.0 for Q2 2018 at Avanos Medical.
In the past five years, Cash from Discontinued Operations ranged from a high of 89900000.0 in Q2 2018 to a low of 89900000.0 in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Discontinued Operations (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	-
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	-
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	-
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	-
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	-
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	-
10	Avanos Medical	1.16 Bn	1.09 Bn	94.20 Mn	-

Download Data

Date	Value
Jun 30, 2018	89.90 Mn
Jun 30, 2018	89.90 Mn